Optimizing Implementation of Long Acting Injectable PrEP

Our goal is to optimize LAI-PrEP implementation within the context of other PrEP methods. Our strategy is flexible to allow pivot to include forthcoming PrEP dosing options should they become available

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

HIV Infections Blood-Borne Infections Communicable Diseases Genital Diseases Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Provider/staff inclusion criteria:

18 years of age or older,
affiliated with a participating clinic, and
be involved in prescribing or supporting PrEP care delivery.

Provider/staff exclusion criteria:

17 years of age or younger,
not affiliated with a participating clinic, and
not involved in prescribing or supporting PrEP care delivery.

De-identified electronic medical record review inclusion criteria:

16 years of age or older, and
had a clinical visit for any form of PrEP care during the study period at a participating clinic site.

De-identified electronic medical record review exclusion criteria:

15 years of age or younger, and
no clinical visit for any form of PrEP care during the study period at a participating clinic site.

Treatment and study plan

Plan-Do-Study-Act

Behavioral

Implementation strategy of conducting cyclical small tests of change using Plan-Do-Study-Act

Primary outcomes

LAI-PrEP prescribing

Time frame: 3 months

Proportion of eligible patients prescribed LAI-PrEP

Study contacts

Contact information is provided by the study sponsor or research team.

Steven A John, PhD, MPH

CONTACT

[email protected]

612-625-1500

Sponsors and collaborators

Lead sponsor

University of Minnesota

Other

Registry information

Important dates

Study start: 2027
Primary completion: 2030
Study completion: 2030
First posted: Jun 16, 2026
Registry last updated: Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting